Skip to main content
Erschienen in: Supportive Care in Cancer 5/2006

01.05.2006 | Original Article

Symptom evaluation in palliative medicine: patient report vs systematic assessment

verfasst von: Jade Homsi, Declan Walsh, Nilo Rivera, Lisa A. Rybicki, Kristine A. Nelson, Susan B. LeGrand, Mellar Davis, Michael Naughton, Dragoslav Gvozdjan, Hahn Pham

Erschienen in: Supportive Care in Cancer | Ausgabe 5/2006

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study examined symptoms reported by patients after open-ended questioning vs those systematically assessed using a 48-question survey.

Materials and methods

Consecutive patients referred to the palliative medicine program at the Cleveland Clinic Foundation were screened. Open-ended questions were asked initially followed by a 48-item investigator-developed symptom checklist. Each symptom was rated for severity as mild, moderate, or severe. Symptom distress was also evaluated. Data were collected using standardized pre-printed forms.

Results

Two hundred and sixty-five patients were examined and 200 were eligible for assessment. Of those assessed, the median age was 65 years (range 17–90), and median ECOG performance status was 2 (range 1–4). A total of 2,397 symptoms were identified, 322 volunteered and 2,075 by systematic assessment. The median number of volunteered symptoms was one (range zero to six). Eighty-three percent of volunteered symptoms were moderate or severe and 17% mild. Ninety-one percent were distressing. Fatigue was the most common symptom identified by systematic assessment but pain was volunteered most often. The median number of symptoms found using systematic assessment was ten (0–25). Fifty-two percent were rated moderate or severe and 48% mild. Fifty-three percent were distressing. In total, 69% of 522 severe symptoms and 79% of 1,393 distressing symptoms were not volunteered. Certain symptoms were more likely to be volunteered; this was unaffected by age, gender, or race.

Conclusion

The median number of symptoms found using systematic assessment was tenfold higher (p<0.001) than those volunteered. Specific detailed symptom inquiry is essential for optimal palliation in advanced disease.
Literatur
1.
Zurück zum Zitat Jemal A, Thomas A, Murray T, Thun M (2002) Cancer statistics. CA Cancer J Clin 52:181–182CrossRef Jemal A, Thomas A, Murray T, Thun M (2002) Cancer statistics. CA Cancer J Clin 52:181–182CrossRef
2.
3.
Zurück zum Zitat Donnelly S, Walsh D, Rybicki L (1995) The symptoms of advanced cancer: identification of clinical and research priorities by assessment of prevalence and severity. J Palliat Care 11(1):27–32PubMed Donnelly S, Walsh D, Rybicki L (1995) The symptoms of advanced cancer: identification of clinical and research priorities by assessment of prevalence and severity. J Palliat Care 11(1):27–32PubMed
4.
Zurück zum Zitat Donnelly S, Walsh D (1995) The symptoms of advanced cancer. Semin Oncol 22(2 Suppl 3):67–72PubMed Donnelly S, Walsh D (1995) The symptoms of advanced cancer. Semin Oncol 22(2 Suppl 3):67–72PubMed
5.
Zurück zum Zitat Walsh D, Donnelly S, Rybicki L (2000) The symptoms of advanced cancer: relationship to age gender and performance status in 1,000 patients. Supportive Care Cancer 8:175–179CrossRef Walsh D, Donnelly S, Rybicki L (2000) The symptoms of advanced cancer: relationship to age gender and performance status in 1,000 patients. Supportive Care Cancer 8:175–179CrossRef
6.
Zurück zum Zitat Simel DL (2004) Approach to the patient: history and physical examination. In: Goldman L, Ausiello D (eds) Cecil textbook of medicine, 22nd edn. WB Saunders, Phildelphia, PA, pp 18–23 Simel DL (2004) Approach to the patient: history and physical examination. In: Goldman L, Ausiello D (eds) Cecil textbook of medicine, 22nd edn. WB Saunders, Phildelphia, PA, pp 18–23
7.
Zurück zum Zitat Stillman MJ, Rybicki LA (2000) The bedside confusion scale: development of a portable bedside test for confusion and its application to the palliative medicine population. J Palliat Med 3(4):449–456PubMedCrossRef Stillman MJ, Rybicki LA (2000) The bedside confusion scale: development of a portable bedside test for confusion and its application to the palliative medicine population. J Palliat Med 3(4):449–456PubMedCrossRef
8.
Zurück zum Zitat Sprangers MA, Aaronson NK (1992) The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: a review. J Clin Epidemiol 45(7):743–760PubMedCrossRef Sprangers MA, Aaronson NK (1992) The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: a review. J Clin Epidemiol 45(7):743–760PubMedCrossRef
9.
Zurück zum Zitat Stromgren AS, Groenvold M, Pedersen L, Olsen AK, Spile M, Sjogren P (2001) Does the medical record cover the symptoms experienced by cancer patients receiving palliative care? A comparison of the record and patient self-rating. J Pain Symptom Manage 21(3):189–196PubMedCrossRef Stromgren AS, Groenvold M, Pedersen L, Olsen AK, Spile M, Sjogren P (2001) Does the medical record cover the symptoms experienced by cancer patients receiving palliative care? A comparison of the record and patient self-rating. J Pain Symptom Manage 21(3):189–196PubMedCrossRef
10.
Zurück zum Zitat Stromgren AS, Groenvold M, Sorensen A, Andersen L (2001) Symptom recognition in advanced cancer. A comparison of nursing records against patient self-rating. Acta Anaesthesiol Scand 45(9):1080–1085PubMedCrossRef Stromgren AS, Groenvold M, Sorensen A, Andersen L (2001) Symptom recognition in advanced cancer. A comparison of nursing records against patient self-rating. Acta Anaesthesiol Scand 45(9):1080–1085PubMedCrossRef
11.
Zurück zum Zitat Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E et al (1994) The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30A(9):1326–1336PubMedCrossRef Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E et al (1994) The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30A(9):1326–1336PubMedCrossRef
12.
Zurück zum Zitat Zobora J, BrintzenhofeSzoc K, Jacobsen P, Curbow B, Piantadosi S, Hooker C et al (2001) A new psychosocial screening instrument for use with cancer patients. Psychosomatics 42(31):241–246CrossRef Zobora J, BrintzenhofeSzoc K, Jacobsen P, Curbow B, Piantadosi S, Hooker C et al (2001) A new psychosocial screening instrument for use with cancer patients. Psychosomatics 42(31):241–246CrossRef
13.
Zurück zum Zitat Heedman PA, Strang P (2001). Symptom assessment in advanced palliative home care for cancer patients using the ESAS: clinical aspects. Anticancer Res 21(6A):4077–4082PubMed Heedman PA, Strang P (2001). Symptom assessment in advanced palliative home care for cancer patients using the ESAS: clinical aspects. Anticancer Res 21(6A):4077–4082PubMed
14.
Zurück zum Zitat Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7:6–9PubMed Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7:6–9PubMed
15.
Zurück zum Zitat Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle MT, Morrissey M et al (2000) Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer 89(7):1634–1646PubMedCrossRef Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle MT, Morrissey M et al (2000) Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer 89(7):1634–1646PubMedCrossRef
16.
Zurück zum Zitat de Haes JC, van Knippenberg FC, Neijt JP (1990) Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 62:1034–1038PubMed de Haes JC, van Knippenberg FC, Neijt JP (1990) Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 62:1034–1038PubMed
17.
Zurück zum Zitat Caraceni A, Cherny N, Fainsinger R, Kaasa S, Poulain P, Radbruch L et al (2002) Pain measurement tools and methods in clinical research in palliative care: recommendations of an expert working group of the European Association of Palliative Care. J Pain Symptom Manage 23(3):239–255PubMedCrossRef Caraceni A, Cherny N, Fainsinger R, Kaasa S, Poulain P, Radbruch L et al (2002) Pain measurement tools and methods in clinical research in palliative care: recommendations of an expert working group of the European Association of Palliative Care. J Pain Symptom Manage 23(3):239–255PubMedCrossRef
18.
Zurück zum Zitat Lloyd-Williams M (2001) Screening for depression in palliative care patients: a review. Eur J Cancer 10(1):31–35CrossRef Lloyd-Williams M (2001) Screening for depression in palliative care patients: a review. Eur J Cancer 10(1):31–35CrossRef
19.
Zurück zum Zitat Kaasa S, Loge JH, Knobel H, Jordhoy MS, Brenne E (1999) Fatigue. Measures and relation to pain. Acta Anaesthesiol Scand 43(9):939–947PubMedCrossRef Kaasa S, Loge JH, Knobel H, Jordhoy MS, Brenne E (1999) Fatigue. Measures and relation to pain. Acta Anaesthesiol Scand 43(9):939–947PubMedCrossRef
20.
Zurück zum Zitat Lloyd-Williams M, Freidman T, Rudd N (2001) An analysis of the validity of the Hospital Anxiety and Depression scale as a screening tool in patients with advanced metastatic cancer. J Pain Symptom Manage 22:990–996PubMedCrossRef Lloyd-Williams M, Freidman T, Rudd N (2001) An analysis of the validity of the Hospital Anxiety and Depression scale as a screening tool in patients with advanced metastatic cancer. J Pain Symptom Manage 22:990–996PubMedCrossRef
21.
Zurück zum Zitat Stromgren AS, Groenvold M, Pedersen L, Olsen AK, Sjogren P (2002) Symptomatology of cancer patients in palliative care: content validation of self-assessment questionnaires against medical records. Eur J Cancer 38(6):788–794PubMedCrossRef Stromgren AS, Groenvold M, Pedersen L, Olsen AK, Sjogren P (2002) Symptomatology of cancer patients in palliative care: content validation of self-assessment questionnaires against medical records. Eur J Cancer 38(6):788–794PubMedCrossRef
22.
Zurück zum Zitat Massie MJ, Popkin MK (1998) Depression. In: Holland J, Rowland J (eds) Handbook of psychooncology. Oxford University Press, New York, pp 518–540 Massie MJ, Popkin MK (1998) Depression. In: Holland J, Rowland J (eds) Handbook of psychooncology. Oxford University Press, New York, pp 518–540
23.
Zurück zum Zitat Walsh D, Rybicki L, Nelson KA, Donnelly S (2002) Symptoms and prognosis in advanced cancer. Support Care Cancer 10:385–388PubMedCrossRef Walsh D, Rybicki L, Nelson KA, Donnelly S (2002) Symptoms and prognosis in advanced cancer. Support Care Cancer 10:385–388PubMedCrossRef
24.
Zurück zum Zitat Homsi J, Walsh D, Nelson KA, LeGrand SB, Davis M, Khawam E, Nouneh C (2002) The impact of a palliative medicine consultation service in medical oncology. Support Care Cancer 10(4):337–342PubMedCrossRef Homsi J, Walsh D, Nelson KA, LeGrand SB, Davis M, Khawam E, Nouneh C (2002) The impact of a palliative medicine consultation service in medical oncology. Support Care Cancer 10(4):337–342PubMedCrossRef
25.
Zurück zum Zitat Ward SE, Goldberg N, Miller-McCauley V, Mueller C, Nolan A, Pawlik-Plank D et al (1993) Patient-related barriers to management of cancer pain. Pain 52(3):319–324PubMedCrossRef Ward SE, Goldberg N, Miller-McCauley V, Mueller C, Nolan A, Pawlik-Plank D et al (1993) Patient-related barriers to management of cancer pain. Pain 52(3):319–324PubMedCrossRef
26.
Zurück zum Zitat Levin DN, Cleeland CS, Dar R (1985) Public attitudes toward cancer pain. Cancer 56(9):2337–2339PubMedCrossRef Levin DN, Cleeland CS, Dar R (1985) Public attitudes toward cancer pain. Cancer 56(9):2337–2339PubMedCrossRef
27.
Zurück zum Zitat Cleeland CS (1987) Barriers to the management of cancer pain. Oncology (Huntingt) 1(2 Suppl):19–26 Cleeland CS (1987) Barriers to the management of cancer pain. Oncology (Huntingt) 1(2 Suppl):19–26
28.
Zurück zum Zitat Diekmann JM, Engber D, Wassem R (1989) Cancer pain control: one state's experience. Oncol Nurs Forum 16(2):219–223PubMed Diekmann JM, Engber D, Wassem R (1989) Cancer pain control: one state's experience. Oncol Nurs Forum 16(2):219–223PubMed
29.
Zurück zum Zitat Mann E, Redwood S (2000) Improving pain management: breaking down the invisible barrier. Br J Nurs 9(19):2067–2072PubMed Mann E, Redwood S (2000) Improving pain management: breaking down the invisible barrier. Br J Nurs 9(19):2067–2072PubMed
30.
Zurück zum Zitat Miaskowski C, Dodd MJ, West C, Paul SM, Tripathy D, Koo P et al (2001) Lack of adherence with the analgesic regimen: a significant barrier to effective cancer pain management. J Clin Oncol 19(23):4275–4279PubMed Miaskowski C, Dodd MJ, West C, Paul SM, Tripathy D, Koo P et al (2001) Lack of adherence with the analgesic regimen: a significant barrier to effective cancer pain management. J Clin Oncol 19(23):4275–4279PubMed
31.
Zurück zum Zitat de Haes JCJM, van Knippenberg FCE, Neijt JP (1990) Measuring psychosocial and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 62(6):1034–1038PubMed de Haes JCJM, van Knippenberg FCE, Neijt JP (1990) Measuring psychosocial and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 62(6):1034–1038PubMed
32.
Zurück zum Zitat Portenoy RK, Thaler HT, Kornblith AB, McCarthy Lepore J, Friedlander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny N, Norton L, Scher H (1994) The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30A(9):1326–1336PubMedCrossRef Portenoy RK, Thaler HT, Kornblith AB, McCarthy Lepore J, Friedlander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny N, Norton L, Scher H (1994) The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30A(9):1326–1336PubMedCrossRef
33.
Zurück zum Zitat Slevin ML, Plant H, Lynch D, Drinkwater K, Gregory WM (1988) Who should measure quality of life, the doctor or the patient? Br J Cancer 57:109–112PubMed Slevin ML, Plant H, Lynch D, Drinkwater K, Gregory WM (1988) Who should measure quality of life, the doctor or the patient? Br J Cancer 57:109–112PubMed
Metadaten
Titel
Symptom evaluation in palliative medicine: patient report vs systematic assessment
verfasst von
Jade Homsi
Declan Walsh
Nilo Rivera
Lisa A. Rybicki
Kristine A. Nelson
Susan B. LeGrand
Mellar Davis
Michael Naughton
Dragoslav Gvozdjan
Hahn Pham
Publikationsdatum
01.05.2006
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 5/2006
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-005-0009-2

Weitere Artikel der Ausgabe 5/2006

Supportive Care in Cancer 5/2006 Zur Ausgabe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Das sind die führenden Symptome junger Darmkrebspatienten

Darmkrebserkrankungen in jüngeren Jahren sind ein zunehmendes Problem, das häufig längere Zeit übersehen wird, gerade weil die Patienten noch nicht alt sind. Welche Anzeichen Ärzte stutzig machen sollten, hat eine Metaanalyse herausgearbeitet.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.